The osmotic pump technology market is anticipated to grow at a rate of 8% from now until 20341. These innovative systems offer a distinct advantage over traditional oral medications by enabling controlled drug release and reducing the frequency of dosing, making them highly patient-centric.
Drugs suitable for PPOP formulations are typically highly potent and have a biological half-life between 1 and 6 hours, with a solubility between 5.0 to 300 mg/mL.
Formulation may seem complex but fully formulated excipients are available to simplify and streamline the manufacturing process. Essentially a PPOP will consist of the following:
A pigmented immediate release top film coating may be applied to provide additional benefits, including branding, product differentiation and improved stability. Additionally, an imprint or branding may be included for product recognition.

Push-Pull Osmotic Pump systems represent a revolutionary advancement in drug delivery, ensuring consistent, controlled, and patient-friendly medication release. With their ability to improve therapeutic outcomes and address diverse medical needs, PPOP technology is set to play a significant role in the future of pharmaceuticals.
1. Osmotic Pump Market Growth – Trends & Forecast 2024-2034, Future Market Insights (2024).